|
WO8901773A1
|
|
Synovial phospholipases
|
|
US5019508A
|
|
Synovial phospholipases
|
|
WO8808457A1
|
|
Hypertension-related blood tests useful as genetic markers
|
|
IE881259L
|
|
Hypertension related blood tests
|
|
EP0269260A2
|
|
apoAI-CIII-AIV, apoAII apoB, apoCI, and LDL receptor polymorphisms for genetic fingerprinting and predictive of atherosclerosis
|
|
EP0236977A2
|
|
Bovine virus diarrhea and hog cholera vaccines
|
|
ZA8608110B
|
|
Blood tests diagnostic for hypertension
|
|
EP0234095A2
|
|
Blood tests diagnostic for hypertension
|
|
IE862792L
|
|
Blood tests diagnostic for hypertension.
|
|
WO8702061A1
|
|
Novel lipoprotein-based drug-delivery systems
|
|
EP0239631A1
|
|
Recombinant apolipoproteins and methods.
|
|
IE862619L
|
|
Lipoprotein-based drug delivery systems
|
|
ZA8607455B
|
|
Polymorphisms related to lipid metabolism predictive of atherosclerosis:apob,apocii,apoe,apoaiv
|
|
IE862572L
|
|
Polymorphism related to lipid metabolism and atherosclerosis
|
|
EP0239629A1
|
|
POLYMORPHISMS RELATED TO LIPID METABOLISM PREDICTIVE OF ATHEROSCLEROSIS: ApoB, ApoCII, ApoE, ApoAIV.
|
|
US4772549A
|
|
Polymorphisms related to lipid metabolism: ApoB, ApoCII, ApoE, ApoAIV
|
|
US4920213A
|
|
Method and compositions useful in preventing equine influenza
|
|
WO8607383A1
|
|
Autoantigen vaccines
|
|
IE861469L
|
|
Autoantigen vaccines
|
|
ES8801127A1
|
|
A procedure for preparing an auto-antigenic vaccine in the form of a modified cowpox virus
|
